Skip to main content

Table 1 Clinical and biochemical parameters for control subjects and diabetic patients, according to quartile of ANGPTL8 levels

From: Predictive values of ANGPTL8 on risk of all-cause mortality in diabetic patients: results from the REACTION Study

Characteristics

Control (ANGPTL8, pg/mL)

p value

Diabetes (ANGPTL8, pg/mL)

p value

Q1 (< 372.15)

Q2 (372.15–537.58)

Q3 (537.59–74.09)

Q4 (> 746.09)

Q1 (< 347.15)

Q2 (347.15–534.23)

Q3 (534.24–810.50)

Q4 (> 810.50)

N

192

193

192

192

 

192

193

192

192

 

ANGPTL8 (pg/ml)

261.28 (188.24–317.25)

432.03 (403.26–476.68)

623.40 (573.62–690.53)

959.43 (850.77–1143.01)

 < 0.001

256.45 (189.45–300.93)

462.97 (406.66–496.93)

642.52 (586.97–729.70)

1009.54 (893.07–1268.33)

 < 0.001

Age (years)

54.44 \(\pm\) 9.03

56.97 \(\pm\) 8.75

59.54 \(\pm\) 8.91

64.87 \(\pm\) 9.82

 < 0.001

59.14 \(\pm\) 9.56

58.30 \(\pm\) 9.37

61.33 \(\pm\) 9.21

63.57 \(\pm\) 9.16

 < 0.001

Male (%)

47 (24.5)

59 (30.6)

68 (35.4)

92 (47.9)

 < 0.001

40 (20.8)

59 (30.6)

68 (35.4)

99 (51.6)

 < 0.001

BMI (kg/m2)

23.39 \(\pm\) 3.16

23.05 \(\pm\) 3.03

23.35 \(\pm\) 2.93

23.71 \(\pm\) 3.21

0.24

24.37 \(\pm\) 3.50

24.79 \(\pm\) 3.44

24.10 \(\pm\) 3.23

23.62 \(\pm\) 3.67

0.009

WHR

0.84 (0.80–0.88)

0.85 (0.81–0.89)

0.85 (0.81–0.90)

0.87 (0.83–0.90)

0.005

0.88 (0.85–0.91)

0.88 (0.84–0.93)

0.88 (0.84–0.92)

0.88 (0.84–0.91)

0.53

SBP

139 (127–156)

145 (129–162)

146 (130–164)

151 (135–168)

 < 0.001

150 (136–168)

149 (135–166)

155 (138–173)

154 (137–173)

0.33

HbA1c (%)

5.50 (5.30–5.80)

5.50 (5.30–5.70)

5.60 (5.40–5.80)

5.60 (5.40–5.90)

0.003

6.50 (5.80–7.70)

6.50 (5.85–8.15)

6.55 (5.90–8.15)

6.40 (5.73–7.80)

0.62

FPG (mmol/L)

5.04 (4.75–5.34)

5.02 (4.77–5.28)

5.00 (4.72–5.26)

5.06 (4.80–5.31)

0.39

7.18 (5.95–8.13)

7.26 (6.19–9.02)

7.37 (6.05–8.98)

7.35 (5.98–8.66)

0.38

2 h PG (mmol/L)

5.72 (4.92–6.42)

5.83 (5.01–6.56)

5.72 (4.91–6.44)

5.84 (5.20–6.63)

0.18

11.38 (7.93–13.72)

12.17 (7.77–15.70)

12.12 (8.31–14.38)

12.06 (9.24–15.74)

0.09

Fasting insulin (pmol/mL)

5.00 (3.50–7.08)

4.80 (3.20–6.90)

4.80 (3.40–7.10)

4.80 (3.40–7.00)

0.58

6.80 (4.30–12.50)

7.10 (4.25–10.95)

6.85 (4.40–10.45)

6.15 (3.63–11.18)

0.48

HOMA-IR

1.19 (0.77–1.62)

1.09 (0.70–1.52)

1.06 (0.74–1.59)

1.06 (0.77–1.59)

0.72

2.24 (1.41–4.04)

2.39 (1.33–4.13)

2.42 (1.34–3.98)

2.17 (1.15–4.00)

0.59

HOMA-\(\beta\)(%)

66.221 (45.56–89.32)

61.76 (44.59–91.01)

70.91 (44.32–100.00)

59.98 (42.72–84.54)

0.20

41.76 (23.60–73.88)

38.76 (18.13–73.84)

36.27 (22.39–63.55)

36.14(17.70–65.55)

0.31

Fasting HDL (mmol/L)

1.37 (1.14–1.60)

1.38 (1.17–1.60)

1.36 (1.15–1.61)

1.34 (1.13–1.61)

0.94

1.44 (1.24–1.70)

1.35 (1.17–1.61)

1.35 (1.16–1.58)

1.32 (1.11–1.62)

0.03

Fasting LDL (mmol/L)

2.43 (2.06–2.96)

2.58 (2.11–3.06)

2.59 (2.10–3.06)

2.62 (2.17–3.04)

0.25

2.93 (2.37–3.64)

2.97 (2.36–3.54)

3.03 (2.42–3.61)

2.83 (2.25–3.50)

0.20

Fasting TG (mmol/L)

1.19 (0.87–1.63)

1.18 (0.90–1.73)

1.16 (0.86–1.74)

1.23 (0.89–1.74)

0.45

1.46 (1.04–2.17)

1.46 (0.95–2.10)

1.49 (1.07–2.08)

1.49 (1.00–2.55)

0.67

Cholesterol (mmol/L)

4.58 (3.92–5.24)

4.67 (4.15–5.30)

4.61 (4.08–5.37)

4.86 (4.19–5.44)

0.10

5.16 (4.57–6.16)

5.13 (4.47–5.85)

5.14 (4.48–5.90)

5.10 (4.38–5.98)

0.78

ALT (U/L)

13 (10–18)

13 (10–17)

14 (11–18)

14 (10–18)

0.48

12 (9–18)

13 (10–19)

14 (10–21)

14 (10–22)

0.05

AST (U/L)

21 (17–25)

23 (19–26)

23 (20–27)

23 (20–28)

 < 0.001

20 (17–26)

21 (17–26)

21 (17–28)

23 (18–31)

0.007

eGFR (mL/min/1.73 m2)

119.54 (107.40–134.39)

119.41 (105.77–130.13)

116.88 (101.22–128.33)

108.12 (92.58–122.90)

 < 0.001

113.51 (100.39–120.63)

111.67 (100.23–120.27)

108.58 (97.16–119.44)

106.71 (90.35–118.79)

0.008

Creatinine (μmol/L)

58.10 (52.33–64.85)

58.50 (53.40–64.45)

61.05 (55.43–66.83)

65.45 (57.18–72.98)

 < 0.001

60.80 (55.90–65.48)

62.00 (56.90–68.05)

63.10 (58.13–69.05)

66.60 (59.85–74.68)

 < 0.001

Currently smoking

19 (10.2)

36 (18.8)

20 (10.6)

43 (23.0)

0.001

15 (8.7)

20 (10.9)

29 (16.1)

50 (26.5)

 < 0.001

Hypertension

96 (50.0)

119 (61.7)

122 (63.5)

141 (73.4)

 < 0.001

143 (74.5)

142 (73.6)

146 (76)

152 (79.2)

0.59

Hyperlipidaemia

62 (32.2)

69 (35.8)

72 (37.0)

85 (44.3)

0.10

113 (58.9)

105 (54.4)

93 (48.4)

124 (64.6)

0.01

  1. BMI body-mass index, WHR waist hip rate, SBP systolic blood pressure, HbA1c glycated haemoglobin A1c, FPG fasting plasma glucose, 2 h PG 2 h plasma glucose concentration, HOMA-IR homeostasis model assessment of insulin resistance, HOMA-β, homeostasis model assessment of β cell function, HDL high density lipoprotein, LDL low density lipoprotein, TG triglycerides, ALT alanine transaminase, AST aspartate aminotransferase, Egfr glomerular filtration rate